Tag Archives: The Stem Cell Blog

BrainStorm Cell Therapeutics’ (BCLI) CEO Chaim Lebovits on Q3 2017 Results – Earnings Call Transcript – Seeking Alpha

Continue reading

2017-10-17 NEWS

Weekly Register

BrainStorm Cell Therapeutics’ (BCLI) CEO Chaim Lebovits on Q3 2017 Results – Earnings Call Transcript
Seeking Alpha
The first patients have been enrolled in the study and we’re also really pleased about the support that we’ve received from CIRM, California stem cell agency to provide funding for this important project. We are working with the top leading ALS centers
BrainStorm Announces Third Quarter 2017 Financial ResultsMarkets Insider
BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn® in ALSGuruFocus.com (blog)
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Getting Somewhat Favorable Press Coverage, Report ShowsThe Ledger Gazette
American Consumer News, LLC
all 45 news articles »
Continue reading

2017-10-17 NEWS

Your Daily Pharma Scoop: Everybody’s Gilead Problem, Halozyme’s Further Progress, ZIOPHARM’s Gene Therapy
Seeking Alpha
ZIOPHARM’s gene therapy Ad-RTS-hIL-12 with veledimex commences trials in pediatric patients with brain tumors. This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare …